CN211583867U - Hypoglycemia emergency device - Google Patents
Hypoglycemia emergency device Download PDFInfo
- Publication number
- CN211583867U CN211583867U CN201922134015.8U CN201922134015U CN211583867U CN 211583867 U CN211583867 U CN 211583867U CN 201922134015 U CN201922134015 U CN 201922134015U CN 211583867 U CN211583867 U CN 211583867U
- Authority
- CN
- China
- Prior art keywords
- cavity
- medicine mixing
- medicine
- mixing cavity
- injector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a hypoglycemia emergency device, diabetes treatment equipment field. The first-aid device for hypoglycemia of the utility model comprises an injector and a medicine mixing cavity; the side wall of the injector is provided with a medicine mixing hole, the side wall of the medicine mixing cavity is provided with a medicine outlet hole, and the medicine mixing hole of the injector is communicated with the medicine outlet hole of the medicine mixing cavity; a rotatable separate cavity is arranged in the medicine mixing cavity, and medicines are filled in the separate cavity; the separated cavity in the rotary medicine mixing cavity corresponds to the medicine outlet hole, and then the medicine in the rotary medicine mixing cavity is filled in a syringe. The hypoglycemia emergency device provided by the utility model provides different treatment schemes for different situations of patients, and the conscious patient can take 15-20g of glucose orally; the glucose gel can be orally taken by people with vague consciousness and dysphagia. Glucose with different concentrations is used for treatment, so as to prevent the occurrence of transfusion extravasation.
Description
Technical Field
The utility model relates to a hypoglycemia emergency device, diabetes treatment equipment field.
Background
Analysis on the occurrence condition of hypoglycemia of inpatients shows that the incidence rate of hypoglycemia of diabetes inpatients is as high as 42.7%, and hypoglycemia can cause damage to multiple system functions and psychological changes, seriously influences the recovery of energy and body role functions of the patients, even can induce myocardial infarction, cerebrovascular accidents or cause accidental injuries such as injury and fracture, and even can cause death of serious patients. Investigation shows that the non-endocrinology hospitalized diabetic patients have the phenomenon of excessive hypoglycemia and irregular treatment, and the correct and timely treatment of the hypoglycemia is one of the prerequisites for ensuring the treatment safety of the diabetic patients. The patent of the utility model aims at providing a convenient and fast's multi-functional hypoglycemia first aid treatment box for clinical medical personnel to improve clinical hypoglycemia standard handling rate.
The current hospital lacks a first-aid kit for treating different cases of hypoglycemia of patients: when hypoglycemia occurs, patients have different consciousness states and swallow conditions and illness state, and the patients need to be prohibited from eating the medicine, and different emergency treatments should be given respectively:
15-20g of glucose can be orally taken by conscious patients;
② the glucose gel can be orally taken by the patient with fuzzy consciousness and dysphagia;
③ patients who need to be fasted, dysphagia or coma due to illness, need to inject glucose intravenously. Patients who are fasted, dysphagic or comatose may be injected intravenously with 10-20% glucose in the peripheral superficial vein, and patients with deep intravenous catheters may be injected intravenously with 50% glucose, since the use of 50% glucose in the peripheral vein is at risk of venous extravasation.
The concentration of glucose for peripheral intravenous injection is recommended to be 10-20%, and the existing first-aid kit does not consider the adverse effect that hypertonic medicines are easy to cause infusion extravasation when used in peripheral veins.
SUMMERY OF THE UTILITY MODEL
The utility model provides a hypoglycemia first aid device to above-mentioned problem.
The utility model adopts the following technical scheme:
the first-aid device for hypoglycemia of the utility model comprises an injector and a medicine mixing cavity; the side wall of the injector is provided with a medicine mixing hole, the side wall of the medicine mixing cavity is provided with a medicine outlet hole, and the medicine mixing hole of the injector is communicated with the medicine outlet hole of the medicine mixing cavity; a rotatable separate cavity is arranged in the medicine mixing cavity, and medicines are filled in the separate cavity; the separated cavity in the rotary medicine mixing cavity corresponds to the medicine outlet hole, and then the medicine in the rotary medicine mixing cavity is filled in a syringe.
In the hypoglycemia emergency treatment device of the utility model, the separate cavity of the medicine mixing cavity is formed by separating the central shaft and the valve; the central shaft is arranged in the medicine mixing cavity, the circumferential surface of the central shaft is provided with a plurality of valves, the valves are arranged along the axial extension direction of the central shaft, and the three valves are arranged in a three-fork shape by taking the central shaft as the center of a circle; a sector-shaped separation cavity is formed between every two adjacent valves and the inner cavity wall of the medicine mixing cavity.
The first-aid device for hypoglycemia of the utility model, the fan-shaped separate cavities in the medicine mixing cavity are respectively a first separate cavity, a second separate cavity and a third separate cavity; the first compartment is filled with coagulation promoting powder, the second compartment is filled with 0.9% normal saline, and the third compartment is filled with normal saline.
The hypoglycemia emergency device of the utility model, the central shaft extends to the outside of the separate cavity, and the extending end part is provided with a rotating handle; the medicine mixing cavity is made of transparent materials.
In the hypoglycemia emergency treatment device of the utility model, the top end of one of the three valves is provided with a blocking sheet; the size of the barrier sheet is larger than that of the medicine outlet hole; the medicine outlet hole is sealed by the blocking sheet.
The first-aid device for hypoglycemia of the utility model, the injector and the medicine mixing cavity are in a separable structure; a sunken slide rail is arranged on the inner side wall of the hole of the medicine mixing hole of the injector; a connecting bridge is arranged outside the medicine outlet hole of the medicine mixing cavity, a sliding plate is arranged at the bottom end of the connecting bridge, and a through hole communicated with the medicine outlet hole is formed in the sliding plate; the edge part in the sliding plate slides into the sinking slide rail from the inlet end of the sinking slide rail to fix the injector and the medicine mixing cavity mutually.
Advantageous effects
The utility model provides a hypoglycemia first aid device, simple structure need not to carry out great change to current syringe, avoids the patient loaded down with trivial details operation to appear in the use.
The utility model provides a hypoglycemia emergency device can prevent that the patient from taking place the mistake and inhaling. The blood sugar of the patient needs to be retested after 15 minutes of hypoglycemia treatment; after the hypoglycemia treatment, the blood sugar is more than 3.9mmol/L, but the time is more than 1h from the next meal, starch or protein containing food needs to be given, otherwise, hypoglycemia is easy to occur again.
The hypoglycemia emergency device provided by the utility model provides different treatment schemes for different situations of patients, and the conscious patient can take 15-20g of glucose orally; the glucose gel can be orally taken by people with vague consciousness and dysphagia. Glucose with different concentrations is used for treatment, so as to prevent the occurrence of transfusion extravasation.
Drawings
Fig. 1 is a schematic structural diagram of the present invention;
fig. 2 is a schematic sectional structure of the present invention;
FIG. 3 is a schematic axial cross-sectional view of the mixing chamber of the present invention;
fig. 4 is a schematic view of the ground structure of the medicine mixing chamber of the present invention.
In the figure, 1 is a syringe, 2 is a medicine mixing cavity, 3 is a medicine mixing hole, 4 is a medicine outlet hole, 5 is a central shaft, 6 is a valve, 7 is a rotating handle, 8 is a first separation cavity, 9 is a second separation cavity, 10 is a third separation cavity, 11 is a separation sheet, 12 is a connecting bridge, 13 is a sinking slide rail, 14 is a sliding plate, and 15 is a through hole.
Detailed Description
In order to make the purpose and technical solution of the embodiments of the present invention clearer, the following description will clearly and completely describe the technical solution of the embodiments of the present invention by combining the drawings of the embodiments of the present invention. It is to be understood that the embodiments described are only some of the embodiments of the present invention, and not all of them. All other embodiments, which can be obtained by a person skilled in the art without any inventive work based on the described embodiments of the present invention, belong to the protection scope of the present invention.
As shown in fig. 1: the utility model discloses medical personnel at first carry out consciousness, swallowing, state of an illness etc. judgement to the hypoglycemia patient in the use, to the different condition of hypoglycemia, give different processing. And reminding the patient that after the hypoglycemia is corrected, the blood sugar is more than 3.9mmol/L, but the time is more than 1h from the next meal, and the food containing starch or protein is given, otherwise, the hypoglycemia is easy to occur. The hypoglycemia emergency device comprises an injector 1 and a medicine mixing cavity 2, wherein the medicine mixing cavity can send an alarm to remind medical staff to retest the blood sugar of a patient 15 minutes after the medical staff starts the objects in the cavity (2017 diabetes prevention and treatment guidelines stipulate that the blood sugar rising condition of the patient is to be monitored after 15 minutes of hypoglycemia treatment); a medicine mixing hole 3 is formed in the side wall of the injector 1, a medicine outlet hole 4 is formed in the side wall of the medicine mixing cavity 2, and the medicine mixing hole 3 of the injector 1 is communicated with the medicine outlet hole 4 of the medicine mixing cavity 2; a rotatable separate cavity is arranged in the medicine mixing cavity 2, and medicines are filled in the separate cavity; the separated cavity in the rotary medicine mixing cavity corresponds to the medicine outlet hole, and then the medicine in the rotary medicine mixing cavity is filled in a syringe.
As shown in fig. 2: the separate cavity of the medicine mixing cavity is formed by separating a central shaft 5 and a valve 6; the central shaft 5 is arranged in the medicine mixing cavity 2, the circumferential surface of the central shaft 5 is provided with a plurality of valves 6, the valves 6 are arranged along the axial extension direction of the central shaft, and the three valves 6 are arranged in a three-fork shape by taking the central shaft 5 as the center of a circle; a sector-shaped separation cavity is formed between every two adjacent valves 6 and the inner cavity wall of the medicine mixing cavity 2.
A separable structure is arranged between the injector 1 and the medicine mixing cavity 2; a sunken slide rail 13 is arranged on the inner side wall of the medicine mixing hole 3 of the injector 1; a connecting bridge 12 is arranged outside the medicine outlet hole 4 of the medicine mixing cavity 2, a sliding plate 14 is arranged at the bottom end of the connecting bridge 12, and a through hole 15 communicated with the medicine outlet hole 3 is arranged in the sliding plate 14; the edge part in the sliding plate 14 slides into the sinking slide rail from the inlet end of the sinking slide rail to fix the injector 1 and the medicine mixing cavity 2 mutually.
As shown in fig. 3: the sectorial separate cavities in the medicine mixing cavity 2 are respectively a first separate cavity 8, a second separate cavity 9 and a third separate cavity 10; a rotary handle 7 is arranged on the extension part outside the central axial separation cavity; the medicine mixing cavity 2 is made of transparent materials.
The first separate chamber 8 is provided with coagulation promoting powder (food thickening agent), the valve 1 is started, the food thickening agent is dispersed into a 50% glucose syringe, glucose gel can be obtained after the food thickening agent is quickly and uniformly shaken up and down, a silica gel suction pipe is placed at the molar teeth of a patient, a syringe handle is pushed, and the gel is slowly pushed into the mouth of the patient. Is suitable for hypoglycemia patients with blurred consciousness and dysphagia.
The second compartment 9 is filled with 45ml of 0.9% normal saline, the valve 2 is started, and 45ml of 0.9% normal saline is mixed with 50% glucose in the syringe to obtain 20% glucose. Is suitable for patients who need intravenous glucose injection and have poor cardiopulmonary function and do not have deep vein catheterization.
The third compartment 10 is filled with 120ml of normal saline, the valve 3 is started, and the 0.9 percent normal saline 120ml is mixed with the 50 percent glucose in the syringe to obtain the 10 percent glucose. Is suitable for patients needing intravenous glucose without deep vein catheterization. The injection device containing 50% glucose is arranged below the box cover, and the injection device is provided with a handle, a piston, a silica gel hose connected with the needle cylinder and a movable needle capable of being opened rotatably. The awake patients can drink directly after the needle is removed. The port of the injection device is in a thread shape and can be connected with the petal-shaped box body.
As shown in fig. 4: the top end of one of the three valves 6 is provided with a blocking sheet 11; the size of the barrier sheet 11 is larger than that of the medicine outlet hole 4; the medicine outlet hole is sealed by the blocking sheet.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present invention should be covered by the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (6)
1. A hypoglycemic emergency device characterized by: comprises an injector and a medicine mixing cavity; the side wall of the injector is provided with a medicine mixing hole, the side wall of the medicine mixing cavity is provided with a medicine outlet hole, and the medicine mixing hole of the injector is communicated with the medicine outlet hole of the medicine mixing cavity; a rotatable separate cavity is arranged in the medicine mixing cavity, and medicines are filled in the separate cavity; the separated cavity in the rotary medicine mixing cavity corresponds to the medicine outlet hole, and then the medicine in the rotary medicine mixing cavity is filled in a syringe.
2. The emergency treatment device for hypoglycemia of claim 1, wherein: the separate cavity of the medicine mixing cavity is formed by separating a central shaft and a valve; the central shaft is arranged in the medicine mixing cavity, the circumferential surface of the central shaft is provided with a plurality of valves, the valves are arranged along the axial extension direction of the central shaft, and the three valves are arranged in a three-fork shape by taking the central shaft as the center of a circle; a sector-shaped separation cavity is formed between every two adjacent valves and the inner cavity wall of the medicine mixing cavity.
3. The emergency hypoglycemic treatment apparatus according to claim 2, wherein: the sector-shaped separate cavities in the medicine mixing cavity are respectively a first separate cavity, a second separate cavity and a third separate cavity; the first compartment is filled with coagulation promoting powder, the second compartment is filled with 0.9% normal saline, and the third compartment is filled with normal saline.
4. The emergency hypoglycemic treatment apparatus according to claim 2, wherein: the central shaft extends towards the outer side of the separate cavity, and the extending end part of the central shaft is provided with a rotating handle; the medicine mixing cavity is made of transparent materials.
5. The emergency hypoglycemic treatment apparatus according to claim 2, wherein: the top end of one of the three valves is provided with a blocking sheet; the size of the barrier sheet is larger than that of the medicine outlet hole; the medicine outlet hole is sealed by the blocking sheet.
6. The emergency treatment device for hypoglycemia of claim 1, wherein: the injector and the medicine mixing cavity are of a separable structure; a sunken slide rail is arranged on the inner side wall of the hole of the medicine mixing hole of the injector; a connecting bridge is arranged outside the medicine outlet hole of the medicine mixing cavity, a sliding plate is arranged at the bottom end of the connecting bridge, and a through hole communicated with the medicine outlet hole is formed in the sliding plate; the edge part in the sliding plate slides into the sinking slide rail from the inlet end of the sinking slide rail to fix the injector and the medicine mixing cavity mutually.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201922134015.8U CN211583867U (en) | 2019-12-03 | 2019-12-03 | Hypoglycemia emergency device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201922134015.8U CN211583867U (en) | 2019-12-03 | 2019-12-03 | Hypoglycemia emergency device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN211583867U true CN211583867U (en) | 2020-09-29 |
Family
ID=72590249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201922134015.8U Expired - Fee Related CN211583867U (en) | 2019-12-03 | 2019-12-03 | Hypoglycemia emergency device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN211583867U (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115429967A (en) * | 2022-09-14 | 2022-12-06 | 中国人民解放军联勤保障部队第九〇〇医院 | Cerebral hemorrhage dredging device convenient to fix on head of patient and using method thereof |
-
2019
- 2019-12-03 CN CN201922134015.8U patent/CN211583867U/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115429967A (en) * | 2022-09-14 | 2022-12-06 | 中国人民解放军联勤保障部队第九〇〇医院 | Cerebral hemorrhage dredging device convenient to fix on head of patient and using method thereof |
CN115429967B (en) * | 2022-09-14 | 2023-10-27 | 中国人民解放军联勤保障部队第九〇〇医院 | Cerebral hemorrhage dredging device convenient to fix on head of patient and use method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
White et al. | Parenteral chloroquine for treating falciparum malaria | |
CN101612425B (en) | Disposable automatic heating and pressurizing transfusion device | |
Davis et al. | A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria | |
Jusko et al. | Precipitation of diazepam from intravenous preparations | |
CN211583867U (en) | Hypoglycemia emergency device | |
CN107440149A (en) | A kind of relevant preparation facilities of quantum information and preparation technology | |
Martin | Hypodermoclysis: renewed interest in an old technique | |
CN206534959U (en) | A kind of stopcock formula filtering injection needle with passage | |
Veall et al. | Thrombocytopenia during treatment with clonazepam. | |
Hilker | Agranulocytosis from Tripelennamine (Pyribenzamine®) Hydrochloride | |
Kovacs et al. | The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion | |
CN215131759U (en) | Rescue box with partition placing function | |
Laithwaite | Paraquat poisoning treated with immunosuppressants and potassium aminobenzoate. | |
CN102370735B (en) | Application of traditional Chinese medicinal composition in preparation of medicament for treating polycythemia | |
CN204261042U (en) | A kind of novel vertical polypropylene transfusion bag | |
CN217612023U (en) | Diaphragm type aseptic medicine storage bottle | |
CN104147047B (en) | A kind of deproteinized calf blood extractive and its injection and preparation method | |
CN216021711U (en) | Cerebral infarction vein thrombolysis first-aid kit | |
Davies et al. | ABC of transfusion. Transfusion of red cells. | |
CN214807413U (en) | Infusion pump pipe | |
Lahane et al. | Purple Glove Syndrome-A Catastrophic Complication of Phenytoin Injection | |
CN101628022A (en) | Safflower dripping pill and preparation method thereof | |
Hasskarl et al. | Complete caval thrombosis secondary to an implanted venous port–a case study | |
CN201006115Y (en) | Multifunctional syringe needle | |
CN204671555U (en) | A kind of bivalve clamping infusion bottle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200929 Termination date: 20211203 |